CLPBF
Coloplast A/S
Set alert
- YTD
- -14.89%
- 1 year
- -23.23%
- Open
- 65.16
- Prev close
- 71.24
- Mkt cap
- 16.06B
- Vol
- 3
- Avg vol
- 723
- EPS
- 1.91
- P/E
- 37.30
More statistics
- Low
- 65.16
- High
- 65.16
- Earnings
- Aug 18, 2026
News
2 months ago reuters.com
Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says
Medical equipment maker Coloplast expects its Kerecis wound-care business to return to growth from January 2027 after changes to U.S. Medicare payments caused sales in outpatient settings to fall…
2 months ago seekingalpha.com
Coloplast Might Have Found Its Bottom
Coloplast remains a 'Buy,' trading ~20% below intrinsic value despite recent struggles and special charges. Organic growth was 6% in Q2-25/26, but reported results were impacted by a DKK 3 billion…
5 months ago seekingalpha.com
Coloplast: Went 'BUY' A Bit Early
Coloplast is rebased to a 20x P/E with a new price target of 490 DKK, reflecting a more realistic valuation post-premiumization. Recent setbacks—the Kerecis acquisition write-down, product recalls,…
5 months ago seekingalpha.com
Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript
Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript
7 months ago seekingalpha.com
Coloplast: The Market Is Throwing Away A High-Quality Compounder
Coloplast is now a clear Buy, trading nearly 60% below its all-time high and at historically low valuation multiples. CLPBF's wide economic moat, underpinned by patents and high switching costs,…
7 months ago globenewswire.com
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons.
7 months ago globenewswire.com
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
8 months ago globenewswire.com
Coloplast appoints Gavin Wood as new CEO
Announcement no. 3/2026 Inside information Coloplast appoints Gavin Wood as new CEO The Coloplast Board of Directors is pleased to announce the appointment of Gavin Wood as the new President and…
8 months ago globenewswire.com
Coloplast A/S - Updated Financial Calendar 2025-26
Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General…
8 months ago seekingalpha.com
Coloplast A/S (CLPBY) Q1 2026 Earnings Call Transcript
Coloplast A/S (CLPBY) Q1 2026 Earnings Call Transcript
8 months ago globenewswire.com
Coloplast A/S - Interim Financial Report, Q1 2025/26
2025/26Interim financial results, Q1 2025/261 October 2025 - 31 December 2025 Coloplast delivered Q1 organic growth of 6% and EBIT growth1 in constant currencies of 3%. Reported revenue in DKK grew…
-
8 months ago globenewswire.com
Coloplast A/S - Interim Financial Report, Q1 2025/26
2025/26Interim financial results, Q1 2025/261 October 2025 - 31 December 2025 Coloplast delivered Q1 organic growth of 6% and EBIT growth1 in constant currencies of 3%. Reported revenue in DKK grew…
10 months ago globenewswire.com
Coloplast announces changes to Executive Leadership Team
Today, Coloplast is announcing changes to the company's Executive Leadership Team (ELT). The changes relate to the company's Interventional Urology business as well as the global People & Culture…
11 months ago seekingalpha.com
Coloplast A/S (CLPBY) Shareholder/Analyst Call Transcript
Coloplast A/S (CLPBY) Shareholder/Analyst Call Transcript
11 months ago globenewswire.com
Coloplast A/S - Decisions at the Annual General Meeting 2025
Today, 4 December 2025, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2024/25 was approved. Distribution of…
12 months ago seekingalpha.com
Coloplast A/S (CLPBY) Q4 2025 Earnings Call Transcript
Coloplast A/S (OTCPK:CLPBY) Q4 2025 Earnings Call November 4, 2025 5:00 AM EST Company Participants Lars Rasmussen Anders Lonning-Skovgaard - Executive VP & CFO Conference Call Participants Hassan…
1 year ago seekingalpha.com
After A 50% Decline, Coloplast Might Finally Be Worth Buying
Coloplast is now rated a cautious 'Buy,' as its valuation has become more reasonable after a significant price correction. Coloplast continues to deliver solid organic growth, boasts a wide economic…
1 year ago globenewswire.com
Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting
Announcement no. 09/2025Inside information Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting Coloplast interim CEO Lars Rasmussen has today…
1 year ago globenewswire.com
Coloplast A/S - Financial Calendar 2025-26
Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://www.coloplast.com/investor-relations/events-calendar/ Kind regards,Investor…
1 year ago seekingalpha.com
Coloplast A/S (CLPBY) Capital Markets Day 2025 Transcript
Coloplast A/S (OTCPK:CLPBY) Capital Markets Day 2025 September 2, 2025 4:30 AM EDT Company Participants Lars Rasmussen Anders Lonning-Skovgaard - Executive VP & CFO Caroline Rosenstand - Executive…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Stocks That Hit 52-Week Highs On Wednesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Stocks That Hit 52-Week Highs On Monday